Peter Heerma serves as the Chief Commercial Officer at Travere Therapeutics Inc., a biopharmaceutical company focused on identifying, developing, and delivering life-changing therapies to people living with rare diseases. In his role, Heerma is responsible for overseeing the company's commercial strategy and operations, ensuring the successful launch and market penetration of Travere's innovative treatments. His leadership is crucial in driving the company's mission to make a meaningful difference in the lives of patients and their families. Heerma brings a wealth of experience to Travere Therapeutics, with a distinguished career in the biopharmaceutical industry spanning over two decades. Prior to joining Travere, he held senior leadership positions at several prominent companies, including Amgen and Genentech, where he demonstrated a proven track record of successfully launching and commercializing groundbreaking therapies. Heerma's expertise in strategic planning, team building, and market analysis has been instrumental in his ability to navigate the complex landscape of rare disease treatments and bring life-changing solutions to patients in need. Under Heerma's guidance, Travere Therapeutics has made significant strides in expanding its commercial footprint and advancing its pipeline of novel therapies. His strategic vision and dedication to the company's mission have been pivotal in fostering a culture of innovation and patient-centricity within the organization. As Chief Commercial Officer, Heerma continues to play a vital role in shaping the future of Travere Therapeutics and ensuring that the company remains at the forefront of rare disease treatment and care.